Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Someone reading a scientific publication on CT Radiomics, sarcopenia, gastric or esophageal cancer

CT-Radiomics unveils insights into sarcopenia's impact on esophageal and gastric cancer prognosis

Analyzing 83 patients with contrast-enhanced CT scans, University Hospital Ulm researchers tracked the prevalence of sarcopenia at different time points. They used mint Lesion™ for muscle segmentation and extraction of 85 radiomic features. These features, categorized into shape, first-order, and higher-order types, provided a detailed assessment of skeletal muscles. Machine learning models, including Random Forest, accurately predicted sarcopenia at the initial diagnosis.

While sarcopenia's link to disease progression lacked statistical significance, the study highlights CT radiomics and machine learning's potential in oncological imaging for refined diagnostics and prognostics.

Related Resources

Related Resources

A picture of Prof. Dr. Thorsten Persigehl next to a quote on the importance of mint Lesion™ for radCIO

Challenges and Opportunities of Setting Up a Comprehensive Oncological Imaging Database

In an exclusive interview with Prof. Dr. Thorsten Persigehl, a leading expert in Oncological Imaging, we delved into the transformative radCIO project…

Interview with Prof. Thorsten Persigehl on the radCIO in Cologne

Structured data in radiology is crucial for accurate diagnoses and treatment planning and serves as the basis for detailed clinical practice and…

Several juxtaposed images of different patients with different responses to the cancer treatment

Study with mint Lesion™ compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis

A study conducted by researchers at University Hospital Tuebingen retrospectively compared two liver-targeted therapies for uveal melanoma patients…